acrolein has been researched along with Respiratory Syncytial Virus Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, LJ; Feng, L; Li, J; Xue, Q; Yu, HB | 1 |
| Chang, JS; Chiang, LC; Lin, CC; Wang, KC | 1 |
2 other study(ies) available for acrolein and Respiratory Syncytial Virus Infections
| Article | Year |
|---|---|
Effects of cinnamaldehyde on anti-respiratory syncytial virus: A protocol of systematic review and meta-analysis.
Topics: Acrolein; Apoptosis; Blotting, Western; Case-Control Studies; Dose-Response Relationship, Drug; HeLa Cells; Humans; Meta-Analysis as Topic; Randomized Controlled Trials as Topic; Research Design; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Systematic Review as Topic | 2020 |
4-Methoxycinnamaldehyde inhibited human respiratory syncytial virus in a human larynx carcinoma cell line.
Topics: Acrolein; Agastache; Cell Line, Tumor; Humans; Interferons; Laryngeal Neoplasms; Phytotherapy; Plant Extracts; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Virus Attachment; Virus Internalization | 2009 |